Compositions and methods for imaging

Patent metadata

Field	Value
Publication number	US-10245330-B2
Application number	US-201715642111-A
Country	US
Kind code	B2
Filing date	Jul 5, 2017
Priority date	Aug 23, 2010
Publication date	Apr 2, 2019
Grant date	Apr 2, 2019

Abstract

The present disclosure provides compositions for in vivo imaging of hydrogen peroxide; and methods for detecting hydrogen peroxide in vivo. The compositions and methods find use in various diagnostic applications, which are also provided.

First claim

What is claimed is:

1. A method of detecting hydrogen peroxide in a cell, tissue, or organ, or extracellularly in an individual, the method comprising:
a) administering to the individual a compound of the formula:

wherein Z is heteroaryl group, wherein the substituted aryl or heteroaryl group comprises one or more R 1 substituent groups each independently selected from a halogen, cyano, nitro, trihalomethyl, alkoxy, aryloxy, alkyl, aryl, heterocycle, thiol, thioether, acyl and hydroxyl, wherein the compound includes one or more isotopically labeled atoms capable of being hyperpolarized by dynamic nuclear polarization at one or more positions selected from the keto carbon and any atom of the substituted aryl or heteroaryl group; and

b) detecting a signal produced by the compound upon reaction with hydrogen peroxide, wherein the compound is hyperpolarized and the detecting is by hyperpolarized magnetic resonance imaging.

2. The method of claim 1 , wherein hydrogen peroxide is selectively detected in a range of from about 2.5 μM to about 250 μM.

3. The method of claim 1 , wherein the individual is a human.

4. The method of claim 1 , wherein said detecting is performed at a first time and at a second time that is later than the first time.

5. The method of claim 4 , wherein the first time is before administration of a therapeutic agent to the individual, and the second time is after administration of a therapeutic agent to the individual.

6. The method of claim 1 , wherein said detecting provides for diagnosis of a disease or disorder characterized at least in part by an excess of hydrogen peroxide.

7. The method of claim 1 , wherein said detecting provides for a determination of the efficacy of a therapeutic agent or other treatment for a disease or disorder characterized at least in part by an excess of hydrogen peroxide.

8. The method of claim 7 , wherein the disease or disorder characterized at least in part by an excess of hydrogen peroxide is cancer, inflammation, aging, cardiovascular disease, diabetes, neurodegenerative disease, or stroke.

9. The method of claim 1 , wherein Z is a substituted pyridyl group.

10. The method of claim 1 , wherein Z is a substituted phenyl group.

11. The method of claim 10 , wherein the compound comprises at least one 13 C atom as shown in one of the following structures:

wherein R 2 is one or more groups, each R 2 independently selected from a halogen, cyano, nitro, a trihalomethyl, an alkoxy, an aryloxy, an alkyl, an aryl, a heterocycle, a thiol, a thioether, an acyl, and hydroxyl.

12. The method of claim 10 , wherein the compound is of the formula:

wherein R 11 , R 12 ,R 13 , R 14 , and R 15 are each independently selected from hydrogen, deuterium, a halogen, cyano, nitro, a trihalomethyl, an alkoxy, an aryloxy, an alkyl, an aryl, a heterocycle, a thiol, a thioether, an acyl, and hydroxyl, wherein at least one of R 11 , R 12 , R 13 , R 14 , and R 15 is not hydrogen and deuterium.

13. The method of claim 10 , wherein the compound is of one of the following formulas:

wherein R 21 , R 22 , R 23 , R 31 , R 32 and R 33 are each independently selected from halogen, cyano, nitro, trihalomethyl, alkoxy, aryloxy, alkyl, aryl, heterocycle, thiol, thioether, acyl, and hydroxyl.

14. The method of claim 10 , wherein the compound is of one of the following structures:

15. The method of claim 9 , wherein the compound is of one of the following formulas:

wherein at least one atom selected from the keto carbon and any atom of the pyridyl group is labeled with an isotope suitable for hyperpolarization by DNP.

16. The method of claim 1 , wherein the at least one isotopically labeled atom is selected from 13 C and 15 N.

17. The method of claim 10 , wherein the compound comprises two or more 13 C labeled atoms.

18. A method of detecting hydrogen peroxide in a cell, tissue, or organ, or extracellularly in an individual, the method comprising:
a) administering to the individual a compound of the formula:

wherein R 2 is one or more groups, each R 2 independently selected from halogen, cyano, nitro, trihalomethyl, and alkoxy; and
b) detecting a signal produced by the compound upon reaction with hydrogen peroxide, wherein the compound is hyperpolarized and the detecting is by hyperpolarized magnetic resonance imaging.

19. The method of claim 18 , wherein the compound is selected from one of the following structures:

20. A method of detecting hydrogen peroxide in a cell, tissue, or organ, or extracellularly in an individual, the method comprising:
a) administering to the individual a compound of one of the following structures:

and
b) detecting a signal produced by the compound upon reaction with hydrogen peroxide, wherein the compound is hyperpolarized and the detecting is by hyperpolarized magnetic resonance imaging.

Assignees

• Univ California

Inventors

• Chang Christopher J
• Lippert Alexander R

Classifications

• A61P35/00

  Antineoplastic agents · CPC title

• A61P29/00

  Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title

• C07C59/88

  containing halogen · CPC title

• C07C59/84

  containing six membered aromatic rings · CPC title

• C07B59/00

  Introduction of isotopes of elements into organic compounds {; Labelled organic compounds per se} · CPC title